The Psychedelic Aspect of Esketamine is an Opportunity, Not a Side Effect | Psychiatry & Behavioral Health Learning Network - Psych Congress Network

The Psychedelic Aspect of Esketamine is an Opportunity, Not a Side Effect | Psychiatry & Behavioral Health Learning Network  Psych Congress NetworkEsketamine, the newly FDA-approved stereoisomer of ketamine, was widely touted this month at the American Psychiatric Association meeting in San Francisco.